Moreover, in consideration of the fact that in our experimental model CD4+ T cells are the first to infiltrate the CIITA-driven MHC-II positive cells in vivo, it is very likely that the initial priming of tumor specific CD4+ Th cells may take place in the tumor tissue, possibly in ectopic lymphoid aggregations outside the canonical lymphoid tissues. The gene discussed is CD4; the disease is neoplasm.